C4 Therapeutics Inc. (CCCC)

AI Score

Unlock

1.57

-0.04 (-2.48%)

At close: Apr 25, 2025, 12:02 PM

C4 Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q4 2018
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	55.5M	59.65M	73.11M	89.66M	126.59M	60.97M	44.88M	49.48M	29.75M	49.55M	57.3M	46M	76.12M	162.75M	281.15M	94.91M	181.73M	63.43M	112.15M	-90.55M	90.55M	-36.31M
Short-Term Investments	189.41M	195.99M	190.98M	168.53M	127.09M	155.6M	222.4M	220.85M	246.4M	264.1M	250.48M	245.17M	233.16M	239.33M	184.76M	218.57M	189.96M	135.98M	103.94M	181.1M	n/a	72.62M
Long-Term Investments	22.36M	n/a	35.08M	44.42M	31.45M	29.86M	19.41M	34.71M	60.96M	52.36M	90.06M	130.48M	142.2M	78.19M	32.77M	32.49M	189.96M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	6.1M	37.46M	2.62M	5.23M	2.72M	6.66M	6.57M	6.64M	4.8M	4.59M	4.59M	4.21M	3.82M	1.85M	1.85M	2.58M	-187.38M	3.08M	2.58M	-90.55M	2.58M	-36.31M
Receivables	3.1M	10.34M	1.17M	13.6M	11.8M	500K	1.03M	528K	1.47M	1.49M	1.71M	1.77M	5.72M	4.84M	6.21M	3.66M	4.48M	4.14M	8.55M	n/a	4.62M	n/a
Inventory	n/a	n/a	1.00	n/a	n/a	1.00	-19.41M	-34.71M	1.00	n/a	n/a	n/a	n/a	1.00	1.00	n/a	n/a	1.00	n/a	n/a	1.00	n/a
Other Current Assets	9.76M	7.25M	10.78M	7.8M	5.71M	6.62M	6.07M	7.6M	9.93M	10.31M	8.88M	10M	10.69M	5.38M	5.44M	4.88M	4.84M	5.37M	n/a	n/a	n/a	n/a
Total Current Assets	257.77M	273.23M	276.04M	279.59M	271.19M	223.69M	274.39M	278.45M	287.56M	325.46M	318.37M	302.95M	325.69M	412.29M	477.56M	322.01M	381.01M	208.92M	227.92M	90.55M	96.77M	36.31M
Property-Plant & Equipment	63.38M	65.37M	67.35M	69.13M	71.09M	72.81M	74.64M	76.24M	77.52M	79.03M	79.46M	77.85M	35.05M	15.57M	16.23M	16.92M	16.55M	17.12M	17.57M	n/a	18.92M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	91.83M	102.83M	105.05M	118.78M	105.26M	109.33M	100.62M	117.58M	143.28M	135.98M	174.11M	212.54M	181.08M	95.62M	50.86M	52M	19.13M	20.2M	20.15M	-90.55M	21.49M	-36.31M
Total Assets	349.6M	376.06M	381.09M	398.37M	376.45M	333.01M	375.01M	396.04M	430.84M	461.44M	492.48M	515.49M	506.76M	507.91M	528.42M	374.01M	400.14M	229.13M	248.07M	n/a	118.26M	n/a
Account Payables	1.33M	1.5M	913K	1.63M	1.45M	1.28M	2.25M	1.03M	1.17M	2.37M	4.45M	3.4M	4.51M	3.75M	4.47M	3.74M	5.68M	5.26M	5.86M	n/a	5.38M	n/a
Deferred Revenue	18.71M	20.77M	36.59M	35.14M	15.47M	8.42M	38.62M	30.78M	16.62M	18.13M	22.17M	31.27M	31.8M	32.29M	28.7M	26.57M	27.6M	23.91M	22.16M	n/a	20.7M	n/a
Short-Term Debt	n/a	5.63M	5.49M	n/a	5.22M	5.09M	15.29M	2.29M	6.99M	6.83M	2.57M	2.48M	n/a	1.18M	1.13M	1.09M	n/a	1M	n/a	n/a	n/a	n/a
Other Current Liabilities	9.3M	4.51M	2.07M	10.26M	8.07M	4.42M	7.54M	14.22M	8.24M	8.02M	11.41M	6.27M	8.52M	6.85M	6.05M	3.8M	5.8M	6.1M	2.76M	n/a	3.62M	n/a
Total Current Liabilities	45.18M	43.29M	54.2M	55.02M	42.77M	30.27M	48.24M	39.38M	44.55M	45.27M	46.15M	46.99M	51.25M	48.69M	44.17M	37.65M	43.85M	40.01M	35.11M	n/a	33.64M	n/a
Long-Term Debt	n/a	n/a	62.92M	n/a	65.76M	67.09M	68.42M	8.62M	9.2M	81.23M	83.74M	84.95M	10.77M	21.51M	21.64M	10.23M	10.05M	21.97M	9.67M	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	-62.92M	n/a	-65.76M	-67.09M	-68.42M	n/a	n/a	-72.18M	-73.37M	-74.75M	n/a	-10.92M	-11.23M	n/a	n/a	-6.63M	n/a	n/a	111M	n/a
Total Long-Term Liabilities	88.44M	90.11M	79.83M	85.07M	87.57M	86.72M	93.06M	94.19M	97.06M	97.99M	101.73M	103.97M	65.91M	60.44M	67.83M	72.65M	75.5M	345.04M	89.17M	n/a	196.58M	n/a
Total Liabilities	133.62M	133.4M	134.03M	140.09M	130.34M	116.99M	141.3M	133.57M	141.61M	143.26M	147.88M	150.96M	117.16M	109.13M	111.99M	110.3M	119.35M	385.05M	124.29M	n/a	230.22M	n/a
Total Debt	65.76M	67.09M	68.42M	69.72M	70.98M	72.18M	83.71M	85.45M	87.15M	88.06M	86.32M	87.42M	42.88M	22.68M	22.77M	22.85M	22.92M	22.97M	22.99M	n/a	13.75M	n/a
Common Stock	7K	7K	7K	7K	6K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K	4K	4K	1K	4K	n/a	n/a	n/a
Retained Earnings	-633.7M	-599.13M	-574.46M	-556.74M	-528.38M	-493.63M	-466.59M	-430.67M	-395.89M	-358.7M	-326.75M	-299.33M	-267.71M	-252.06M	-227.37M	-204.79M	-183.82M	-162.03M	-140.19M	n/a	-117.49M	n/a
Comprehensive Income	53K	455K	-440K	-380K	-127K	-904K	-1.77M	-2.47M	-4.14M	-5.41M	-4.58M	-3.65M	-775K	-155K	-69K	-94K	13K	8K	-2K	-111.96M	-3.95M	-79.75M
Shareholders Equity	215.99M	242.66M	247.06M	258.28M	246.11M	216.02M	233.71M	262.47M	289.23M	318.18M	344.59M	364.53M	389.61M	398.78M	416.43M	263.7M	280.79M	-155.92M	123.78M	-968K	-111.96M	31.25M
Total Investments	211.76M	195.99M	226.06M	212.95M	158.54M	155.6M	222.4M	220.85M	307.36M	316.46M	340.54M	375.65M	375.36M	317.52M	217.53M	251.06M	379.92M	135.98M	103.94M	181.1M	n/a	72.62M